Sinovac Snags Another Large Order for Flu Vaccine

Sinovac Biotech has received a very large order for 5.2 million doses of its H1N1 vaccine, Panflu.1. This is the third order Sinovac has received from various official China agencies, bringing the total to 11.5 million doses. Regarding a separate program, Sinovac also said it won the bidding process to supply its seasonal flu vaccine, Anflu, to the Shanghai government. More details... Stock Symbol: (NYSE Amex: SVA)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.